NCT05387330View on ClinicalTrials.gov

Dynamic Changes in the Levels of sCD62L and SPARC in Chronic Myeloid Leukemia Patients During Imatinib Treatment

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

July 25, 2021

Study Completion Date

December 28, 2021

Conditions
Chronic Myeloid Leukemia
Interventions
DIAGNOSTIC_TEST

ELISA kit

Sandwich ELISA kit for the accurate quantitative detection of sCD62L and SPARC in human plasma and serum samples.

Trial Locations (1)

31511

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT05387330 - Dynamic Changes in the Levels of sCD62L and SPARC in Chronic Myeloid Leukemia Patients During Imatinib Treatment | Biotech Hunter | Biotech Hunter